Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
115.20
Nov 17 • 3:59 PM ET Dollar change-1.55 Percentage change(-1.33%)
Aftermarket Close
115.20
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Index
RUT
Market Cap
1.93B
Enterprise Value
1.66B
Income
-106.10M
Sales
6.00B
Book/sh
16.72
Cash/sh
18.56
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
856
IPO
Apr 15, 2021
P/E
-
Forward P/E
33.27
PEG
-
P/S
0.32
P/B
6.89
P/C
6.21
P/FCF
-
EV/EBITDA
-
EV/Sales
0.28
Quick Ratio
1.13
Current Ratio
1.13
Debt/Eq
0.12
LT Debt/Eq
0.07
Option/Short
Yes / Yes
EPS (ttm)
-6.58
EPS next Y
3.46
EPS next Q
-3.37
EPS this Y
102.19%
EPS next Y
545.08%
EPS next 5Y
-
EPS past 3/5Y
-55.37% -36.60%
Sales past 3/5Y
35.43% 37.24%
EPS Y/Y TTM
66.99%
Sales Y/Y TTM
2.02%
EPS Q/Q
129.69%
Sales Q/Q
5.86%
Insider Own
30.23%
Insider Trans
0.00%
Inst Own
72.93%
Inst Trans
8.16%
ROA
-6.71%
ROE
-36.15%
ROIC
-35.45%
Gross Margin
2.53%
Oper. Margin
-1.66%
Profit Margin
-1.77%
SMA20
14.52%
SMA50
25.40%
SMA200
64.36%
Trades
Shs Outstand
16.80M
Shs Float
11.72M
52W High
133.04 -13.41%
52W Low
7.48 1440.11%
Volatility
5.47% 6.60%
ATR (14)
6.72
RSI (14)
69.99
Beta
3.00
Rel Volume
0.98
Avg Volume
216.59K
Volume
211,283
Perf Week
1.48%
Perf Month
29.69%
Perf Quarter
23.02%
Perf Half Y
30.61%
Perf YTD
569.09%
Perf Year
758.10%
Perf 3Y
-61.41%
Perf 5Y
-81.78%
Perf 10Y
-
Prev Close
116.75
Price
115.20
Change %
-1.33%
Consensus
Hold
Avg. Price Target
$124.33
Implied Upside
+7.9%
Analysts12incl. previous ratings
Rating Distribution3 Buy · 7 Hold · 2 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Sep 15, 2026Upgrade
BBernstein
Mkt Perform → Outperform$125+8.5%
Aug 11, 2026Upgrade
C logoCCitigroup
Sell → Neutral$115-0.2%
Jul 23, 2026Downgrade
C logoCCitigroup
Neutral → Sell$105-8.9%
May 26, 2026Upgrade
BCS logoBBarclays
Underweight → Equal Weight$81-29.7%
May 07, 2026Upgrade
JEF logoJJefferies
Hold → Buy$48-58.3%
May 07, 2026Upgrade
DB logoDDeutsche Bank
Hold → Buy$49-57.5%
May 04, 2026Downgrade
JPM logoJJP Morgan
Neutral → Underweight$21-81.8%
Aug 20, 2025Downgrade
BBernstein
Outperform → Mkt Perform$1.40-98.8%
Aug 06, 2025Downgrade
C logoCCitigroup
Buy → Neutral$1-99.1%
Apr 25, 2025Upgrade
C logoCCitigroup
Neutral → Buy$5-95.7%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shaker BenjaminChief Markets OfficerMar 02 '26Buy0.60500,000301,0501,367,674Mar 03 05:28 PM
Agilon Health, Inc. engages in the provision of healthcare services. It also provides capital, data, payor relationships, executive experience, and contract support that allow physician groups to take on the risk of total care for their patients. The company was founded by Ronald A. Williams and Veeral Desai in 2016 and is headquartered in Westerville, OH.
CEO & DirectorMr. Timothy Patrick O'Rourke
Chief Accounting OfficerMr. Timothy Gertsch
Interim Chief Technology OfficerMr. Varun Anand
Senior Vice President of Investor RelationsMr. Evan Smith C.F.A.
Chief of Technology InnovationMr. Bill Farry